ALBEMARLE CORP
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 12/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 3,194 | 25.1 |
| Stockholders' equity | 9,533 | 74.9 |
| Total capitalization | 12,727 | 100.0 |
118,005,057 shares outstanding at 29 July 2026 (cover page of the 10-Q filed 5 August 2026).
LONG-TERM DEBT 12/31/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 3,194 |
| Long-term debt, noncurrent | 3,119 |
| Current maturities | 74 |
CAPITAL STOCK 12/31/25
| Common shares authorized | 275,000,000 |
| Common shares issued | 117,716,000 |
| Par or stated value per share ($) | 0.01 |
| Preferred stock ($ millions) | 2,235 |
| Outstanding at 7/29/26 | 118,005,057 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | 1.62 | – |
| 2024 | 1.61 | – |
| 2023 | 1.60 | 12.0 |
| 2022 | 1.58 | 6.9 |
| 2021 | 1.56 | 147.2 |
HISTORY AND BUSINESS
HISTORY: Incorporated in Virginia.
BUSINESS: Classified by the SEC under Standard Industrial Classification 2821, Plastic Materials, Synth Resins & Nonvulcan Elastomers. Large accelerated filer. Principal executive office: 4250 Congress Street, Suite 900, Charlotte, NC 28209. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 12/31/25 | 12/31/24 | 12/31/23 |
|---|---|---|---|
| Revenues | 5,143 | 5,378 | 9,617 |
| Cost of revenues | 4,474 | 5,315 | 8,431 |
| Gross profit | 669 | 63 | 1,186 |
| Research and development | 51 | 87 | 86 |
| Selling, general and administrative | 550 | 618 | 910 |
| Depreciation and amortization | 659 | 589 | 430 |
| Operating income | (367) | (1,777) | 252 |
| Income before income taxes | (552) | (1,764) | 247 |
| Income taxes | 157 | 87 | 430 |
| Net income | (511) | (1,179) | 1,573 |
| Earned per share, diluted ($) | (5.76) | (11.20) | 13.36 |
| Dividends per share ($) | 1.62 | 1.61 | 1.60 |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 12/31/25 | 12/31/24 |
|---|---|---|
| Receivables, net | 594 | 742 |
| Inventories | 1,179 | 1,503 |
| Total current assets | 4,008 | 3,842 |
| Property, plant and equipment, net | 8,612 | 9,331 |
| Goodwill | 1,500 | 1,583 |
| Total assets | 16,374 | 16,610 |
| Total current liabilities | 1,798 | 1,966 |
| Long-term debt | 3,119 | 3,118 |
| Stockholders' equity | 9,533 | 9,962 |
| Total liabilities and equity | 16,374 | 16,610 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/25 | 5,143 | (367) | (511) | -9.9 | (5.76) | 1.62 | 1,282 | 590 | 692 | 16,374 | 6,593d | 3,194 | 9,533 | -5.4 | 0.33 |
| 12/31/24 | 5,378 | (1,777) | (1,179) | -21.9 | (11.20) | 1.61 | 688 | 1,681 | (993) | 16,610 | 6,410d | 3,516 | 9,962 | -11.8 | 0.35 |
| 12/31/23 | 9,617 | 252 | 1,573 | 16.4 | 13.36 | 1.60 | 1,327 | 2,155 | (828) | 18,271 | 8,606d | 4,167 | 9,412 | 16.7 | 0.44 |
| 12/31/22 | 7,320 | 2,470 | 2,690 | 36.7 | 22.84 | 1.58 | 1,908 | 1,262 | 646 | 15,457 | 7,266d | 3,217 | 7,983 | 33.7 | 0.40 |
| 12/31/21 | 3,328 | 798 | 124 | 3.7 | 1.06 | 1.56 | 344 | 954 | (609) | 10,974 | 5,169d | 2,394 | 5,625 | 2.2 | 0.43 |
| 12/31/20 | 3,129 | 506 | 376 | 12.0 | 3.52 | 1.54 | 799 | 850 | (52) | 10,451 | 5,982d | 3,572 | 4,268 | 8.8 | 0.84 |
| 12/31/19 | 3,589 | 666 | 533 | 14.9 | 5.02 | 1.47 | 719 | 852 | (132) | 9,861 | 5,767d | 3,050 | 3,932 | 13.6 | 0.78 |
| 12/31/18 | 3,375 | 912 | 694 | 20.6 | 6.34 | 1.34 | 546 | 700 | (154) | 7,582 | 3,823d | 1,705 | 3,585 | 19.3 | 0.48 |
| 12/31/17 | 3,072 | 572 | 55 | 1.8 | 0.49 | 1.28 | 304 | 318 | (14) | 7,751 | 3,933d | 1,837 | 3,675 | 1.5 | 0.50 |
| 12/31/16 | 2,677 | 601 | 644 | 24.0 | 5.68 | 1.22 | 736 | 197 | 539 | 8,161 | 4,219d | 2,369 | 3,795 | 17.0 | 0.62 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
ALBEMARLE CORP
CIK 915913 · EIN 54-1692118
PRINCIPAL OFFICE:
4250 Congress Street, Suite 900, Charlotte, NC 28209
Tel.: 980-299-5700
INCORPORATED:
Virginia
INDUSTRY (SEC SIC CODE):
2821 · Plastic Materials, Synth Resins & Nonvulcan Elastomers
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 12/31/25, filed 11 February 2026
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/11/26) · 10-K FY2024 (filed 2/12/25) · 10-K FY2023 (filed 2/15/24) · 10-K FY2021 (filed 2/15/23) · 10-K FY2021 (filed 2/22/22) · 10-K FY2020 (filed 2/19/21) · 10-K FY2019 (filed 2/26/20) · 10-K FY2018 (filed 2/27/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.